Assessing the Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Undiagnosed Young Adults:A Cross Sectional Study
April 21, 2024 updated by: Aina Marzia Syed, Jinnah Sindh Medical University
To asses the prevalence of Attention deficit hyperactivity disrorder in undiagnosed young adults.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Finding the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) in undiagnosed young adults using the questionnaire provided by WHO ,
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 75330
- JSMU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
Young adults between age group of 18-24
Description
Inclusion Criteria:
- undiagnosed
Exclusion Criteria:
- diagnosed with any mental disability
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Age group
18-20 21-22 22-24
|
|
|
ASRS V1.1 scores(%)
Score of Ahdh self report scale questionnaire
|
Diagnosing the behavioral pattern
|
|
ADHD symptom prevalence
People who got more than 4 in part A of questionnaire and more than 6 in Part B
|
Diagnosing the behavioral pattern
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess the prevalence of undiagnosed ADHD in Young adults
Time Frame: 2 months
|
To find out the prevalence of ADHD in Young adults
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Aina M Syed, Jinnah Sindh Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2023
Primary Completion (Actual)
September 1, 2023
Study Completion (Actual)
September 1, 2023
Study Registration Dates
First Submitted
April 21, 2024
First Submitted That Met QC Criteria
April 21, 2024
First Posted (Actual)
April 25, 2024
Study Record Updates
Last Update Posted (Actual)
April 25, 2024
Last Update Submitted That Met QC Criteria
April 21, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 009-0001-7719-1189
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.